Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 36 checked references that resolve
resolves10.1088/1468-6996/16/2/023501Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications
resolves10.1166/jbn.2008.007Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging
resolves10.1039/C1CS15248CDesigned synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents
resolves10.1039/c3tb20322kHighly water-soluble magnetic iron oxide (Fe3O4) nanoparticles for drug delivery: enhanced in vitro therapeutic efficacy of doxorubicin and MION conjugates
resolves10.1016/j.jmmm.2016.05.019Recent advances in synthesis and surface modification of superparamagnetic iron oxide nanoparticles with silica
resolves10.1016/j.ijpharm.2015.10.058Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics
resolves10.1039/C4NR03482AMagnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer
resolves10.1016/j.jmmm.2019.01.102Synthesis and characterization of Gd3+- and Tb3+-doped iron oxide nanoparticles for possible endoradiotherapy and hyperthermia
resolves10.1016/j.jmmm.2005.01.064Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
resolves10.3390/ma11122388A Hybrid System for Magnetic Hyperthermia and Drug Delivery: SPION Functionalized by Curcumin Conjugate
resolves10.1038/nrc3672Thermal ablation of tumours: biological mechanisms and advances in therapy
resolves10.3390/molecules21101357Small versus Large Iron Oxide Magnetic Nanoparticles: Hyperthermia and Cell Uptake Properties
resolves10.1039/C7TB01305ATrastuzumab-decorated nanoparticles for in vitro and in vivo tumor-targeting hyperthermia of HER2+ breast cancer
resolves10.1080/21691401.2018.1501380Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer
resolves10.1021/mp5007618Trastuzumab Labeled to High Specific Activity with <sup>111</sup>In by Site-Specific Conjugation to a Metal-Chelating Polymer Exhibits Amplified Auger Electron-Mediated Cytotoxicity on HER2-Positive Breast Cancer Cells
resolves10.1002/chem.200800369Synthesis, Surface Modifications, and Size‐Sorting of Mixed Nickel–Zinc Ferrite Colloidal Magnetic Nanoparticles
resolves10.1016/j.jallcom.2012.10.009Cation distribution by Rietveld technique and magnetocrystalline anisotropy of Zn substituted nanocrystalline cobalt ferrite
resolves10.1186/s12938-017-0327-xPhysical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review
resolves10.1007/s11671-010-9729-4Synthesis of Bio-Compatible SPION–based Aqueous Ferrofluids and Evaluation of RadioFrequency Power Loss for Magnetic Hyperthermia
resolves10.1371/journal.pone.0088239DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy
The 4 references without a DOI — listed, not checked
no DOI — not checkedMagnetic nanoparticles in cancer diagnostics, drug delivery and treatment (Review)
no DOI — not checkedApplication of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment
no DOI — not checkedTrastuzumab: Updated mechanisms of action and resistance in breast cancer
no DOI — not checkedTrastuzumab-modified DM1-loaded nanoparticles for HER2+ breast cancer treatment: An in vitro and in vivo study
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.